LONDON, April 2, 2014 /PRNewswire/ --

On Tuesday, April 01, 2014, the US markets saw a positive sentiment, with the NASDAQ Composite closing at 4,268.04, up 1.64%, the Dow Jones Industrial Average ending the session at 16,532.61, up 0.46% and the S&P 500 edging 0.70% higher to finish the trading session at 1,885.52. The session saw a positive impact from Consumer Discretionary, Information Technology and Industrials sectors along with a drag from Utilities, and Consumer Staples sectors. A number of stocks saw large movements, including JinkoSolar Holding Co. Ltd (NYSE: JKS), Horizon Pharma Inc. (NASDAQ: HZNP), YY Inc. (NASDAQ: YY) and Questcor Pharmaceuticals Inc. (NASDAQ: QCOR). Free technical research on JKS, HZNP, YY and QCOR can be downloaded upon signing up at:

http://www.investor-edge.com/688-register

Shares in JinkoSolar Holding Co Ltd finished Tuesday's session at $31.24, recording a gain of 11.77%. A total of 2.98 million shares were traded which is above the three months average volume of 2.52 million shares. The stock vacillated between $28.22 and $31.44 during the session and traded at a PE ratio of 37.36. Shares in JinkoSolar Holding Co Ltd have advanced 14.77% in the previous three trading sessions and 6.62% on YTD basis, while the same has fallen by 4.52% in the last one month. The S&P 500 Information Technology Sector Index mapped a gain of 1.32% during the trading session and charted up 3.20% in the previous three months. Additionally, the stock has a Relative Strength Index (RSI) of 40.98 and is trading above its 50-day and 200-day moving averages of $30.99 and $23.48, respectively. Sign up today to read free research on JKS at:

http://www.investor-edge.com/688-JKS-02Apr2014.pdf

On Tuesday, Horizon Pharma Inc.'s stock ended the day at $16.07, which is 6.28% higher than the previous day's closing price of $15.12. A total of 2.76 million shares were traded as compared to the three months average volume of 2.53 million shares. During the session, the stock oscillated between $15.21 and $16.25. Shares of Horizon Pharma Inc. have rallied 31.51% in the last one month and 110.89% on YTD basis. The S&P 500 Health Care Sector Index mapped a gain of 0.70% during the trading session, while the same has declined 0.69% in the last one month. Further, the stock has an RSI of 59.55 and is trading above its 50-day and 200-day moving averages of $11.93 and $6.15, respectively. Sign up today to read free research on HZNP at:

http://www.investor-edge.com/688-HZNP-02Apr2014.pdf

YY Inc.'s stock edged 7.18% higher, finishing Tuesday's session at $81.84. A total of 2.62 million shares were traded as compared to a three months average volume of 2.24 million shares. The stock fluctuated between $77.16 and $82.26 during the trading session and traded at a PE ratio of 62.03. YY Inc.'s shares have surged 15.25% in the previous three trading sessions, 8.70% in the last one month and 62.77% on YTD basis. The S&P 500 Information Technology Sector Index mapped a gain of 1.32% during the trading session and charted up 1.53% in the last one month. Furthermore, the stock has an RSI of 50.76 and is trading above its 50-day and 200-day moving averages of $72.05 and $51.78, respectively. Sign up today to read free research on YY at:

http://www.investor-edge.com/688-YY-02Apr2014.pdf

Shares in Questcor Pharmaceuticals Inc. closed Tuesday's session at $69.47, up 6.99% with a trading volume of 2.56 million shares as compared to a three months average volume of 2.34 million shares. The stock traded between $65.12 and $69.70 during the session and traded at a PE ratio of 14.29. Shares in Questcor Pharmaceuticals Inc. have gained 10.34% in the previous three trading sessions, 14.35% in the last one month, and 27.58% on YTD basis. The S&P 500 Health Care Sector Index mapped a gain of 0.70% during the trading session and charted up 6.14% in the previous three months. Moreover, the stock has an RSI of 51.59 and is trading above its 50-day and 200-day moving averages of $66.06 and $59.90, respectively. Sign up today to read free research on QCOR at:

http://www.investor-edge.com/688-QCOR-02Apr2014.pdf

=============== EDITOR'S NOTES: ===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-edge. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Investor-edge in this article or report according to the Procedures outlined by Investor-edge. Investor-edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE Investor-edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED Investor-edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

SOURCE Investor-Edge